IRIS
ROMEO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.744
NA - Nord America 1.832
AS - Asia 1.532
SA - Sud America 227
Continente sconosciuto - Info sul continente non disponibili 94
AF - Africa 31
OC - Oceania 2
Totale 7.462
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.741
US - Stati Uniti d'America 1.763
IT - Italia 546
SG - Singapore 509
CN - Cina 366
VN - Vietnam 214
BR - Brasile 180
HK - Hong Kong 175
IE - Irlanda 174
KR - Corea 84
DE - Germania 82
JP - Giappone 61
IN - India 53
FR - Francia 39
GB - Regno Unito 38
NL - Olanda 30
CA - Canada 28
AR - Argentina 22
AT - Austria 20
MX - Messico 17
FI - Finlandia 15
BD - Bangladesh 13
ID - Indonesia 10
ZA - Sudafrica 10
ES - Italia 9
EC - Ecuador 8
IQ - Iraq 8
CO - Colombia 7
PK - Pakistan 7
PL - Polonia 7
EG - Egitto 6
GR - Grecia 6
TR - Turchia 6
UA - Ucraina 6
SE - Svezia 5
TT - Trinidad e Tobago 5
CZ - Repubblica Ceca 4
MY - Malesia 4
UZ - Uzbekistan 4
BB - Barbados 3
BE - Belgio 3
KE - Kenya 3
LT - Lituania 3
MA - Marocco 3
PE - Perù 3
SC - Seychelles 3
VE - Venezuela 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
MK - Macedonia 2
NI - Nicaragua 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CH - Svizzera 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
ET - Etiopia 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
JO - Giordania 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
Totale 7.369
Salva come PNG Salva come JPEG
Città #
Moscow 962
San Jose 284
Singapore 259
Ashburn 231
Dublin 172
Hong Kong 170
Santa Clara 151
Naples 132
Council Bluffs 126
Hefei 90
Seoul 84
Ho Chi Minh City 82
Beijing 66
Chandler 59
New York 54
Milan 50
Hanoi 47
Dallas 44
Los Angeles 36
Rome 30
Bengaluru 29
Boardman 25
Munich 21
São Paulo 18
Amsterdam 17
Orem 17
Paris 16
Da Nang 15
North Bergen 14
Boydton 13
Bremen 13
Nuremberg 13
Vienna 13
Atlanta 12
Chicago 12
Phoenix 12
Caserta 11
Princeton 11
Cambridge 10
Denver 10
Frankfurt am Main 10
Roxbury 10
Tokyo 10
Viterbo 10
Haiphong 9
Mexico City 9
Miano 9
Salerno 9
San Francisco 9
The Dalles 9
Chennai 8
Montreal 8
Aversa 7
Falkenstein 7
Memphis 7
Belo Horizonte 6
Casoria 6
Des Moines 6
Fondi 6
Houston 6
Newark 6
Sennori 6
Toronto 6
Turku 6
Warsaw 6
Brasília 5
Brooklyn 5
Buffalo 5
Curitiba 5
Helsinki 5
Hillsboro 5
Kochi 5
Manassas 5
Ninh Bình 5
Pavia 5
Baghdad 4
Bari 4
Biên Hòa 4
Boston 4
Cairo 4
Cesa 4
Chaguanas 4
Dormagen 4
Hải Dương 4
Jacksonville 4
Johannesburg 4
Lappeenranta 4
London 4
Manchester 4
Sialkot 4
Tashkent 4
Tianjin 4
Verona 4
Vũng Tàu 4
Barcelona 3
Bisaccia 3
Bologna 3
Bridgetown 3
Brussels 3
Catania 3
Totale 3.766
Salva come PNG Salva come JPEG
Nome #
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 193
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 188
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 183
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 178
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 172
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the "Bermuda" triangle of malnutrition-sarcopenia-frailty severely affecting prognosis 171
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 162
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 157
The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study 153
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 153
INTESTINAL MICROBIOTA, INTESTINAL PERMEABILITY AND THE UROGENITAL TRACT: IS THERE A PATHOPHYSIOLOGICAL LINK? 150
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 149
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 148
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 147
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis 147
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review 145
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 145
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 144
Are insulin resistance and non-alcoholic fatty liver disease associated with Peyronie's disease? A pilot study 140
Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review 139
The Burden of Irritable Bowel Syndrome in Medical and Nurse Italian University Student Population: The VANVITELLI-IBS Survey 138
Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications 138
Exploring the Classic and Novel Pathogenetic Insights of Plastic Exposure in the Genesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 136
Intestinal pseudo-obstruction as systemic lupus erythematosus complication: is it time to reconsider the role of surgery? A case report of a tailored multidisciplinary managed 44-year-old male patient 134
Environmental bisphenol A exposure triggers trained immunity-related pathways in monocytes 133
Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain 133
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial 130
Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review 128
Systemic Oxidative Stress Correlates with Sarcopenia and Pruritus Severity in Primary Biliary Cholangitis (PBC): Two Independent Relationships Simultaneously Impacting the Quality of Life—Is the Low Absorption of Cholestasis-Promoted Vitamin D a Puzzle Piece? 126
Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider? 126
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)? 125
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression 125
Spleen Area Affects the Performance of the Platelet Count–Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction–Associated Steatotic Liver Disease Cirrhosis 124
The role of fructose in non-alcoholic steatohepatitis: Old relationship and new insights 123
Vanek's Tumour as a Rare Cause of Dyspeptic Syndrome in a Patient with Primary Biliary Cholangitis: A Case Report 121
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 121
Nutrigenomics and nutrigenetics in metabolic-(Dysfunction) associated fatty liver disease: Novel insights and future perspectives 115
Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The "BE-FIT-IBD" study 113
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition 112
Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study 110
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications 110
The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications 110
From “Traditional” to “Trained” Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 109
Phase Angle/C-reactive Protein-Index as a Novel Combined Tool for Predicting Liver-Related Hospitalizations in MASLD-Decompensated Cirrhosis 109
Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future? 108
Letter: Different Risk of Acute Variceal Bleeding According to the Liver Disease Aetiology in Decompensated Cirrhosis Patients Receiving Carvedilol‐Based Primary Prophylaxis—May Insulin Resistance Unloose This Gordian Knot? 108
Primary biliary cholangitis, Celiac Disease, and MASLD: the triumvirate of steatosis. How should we manage this triple overlap? 106
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 103
Urinary volatile Organic compounds in non-alcoholic fatty liver disease (NAFLD), type two diabetes mellitus (T2DM) and NAFLD-T2DM coexistence 102
Is it time to reconsider the MRP6 role in bile secretion and LPAC genetic signature? 102
Beneficial Effects of Long-Lasting Bicarbonate–Sulfate–Calcium–Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcomes via Impacting Intestinal Permeability (IP), IP-Related Systemic Inflammation, and Oxidative Stress 101
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV) 96
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm 92
Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach 89
Pneumococcal vaccination status among cirrhotic patients in Italy: a neglected topic 84
The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives 46
From “MAFLD” to “MASLD”: Was This Revolution Worth It? A Head-to-Head Comparison of MAFLD and MASLD Criteria in Estimating Liver Disease Progression and Cardiovascular Risk in Real Life 46
Human Albumin-enriched Peritoneal Dialysis: A Novel Approach to Manage Refractory Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease 37
Contrast-enhanced ultrasound as a problem-solving tool and irreversible electroporation for a perivascular/peribiliary segment IVs colorectal liver metastasis: a case report 29
Redefining Liver Transplantation Indications for Hepatic Malignancies in the Era of Precision Transplant Oncology: An Up-to-Date Narrative Review 28
Beyond Insulin Resistance: Exploring the Centrality of the Gut–Liver Axis in Mediating Immunometabolic Dysregulation Driving Hepatocellular Carcinoma in MASLD and Diabetes 27
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study 25
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Chronic Liver Diseases: Translating Mechanistic Insights into Clinical Practice and Future Perspectives 20
Totale 7.462
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.075
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202298 0 0 0 14 15 9 1 0 5 4 27 23
2022/2023348 17 9 6 20 75 17 2 14 156 9 13 10
2023/2024323 19 11 24 29 55 58 9 9 5 10 31 63
2024/2025804 22 16 16 38 119 92 105 91 95 65 81 64
2025/20264.896 209 346 264 183 420 2.565 236 219 156 118 101 79
2026/2027912 37 167 296 412 0 0 0 0 0 0 0 0
Totale 7.462